169 related articles for article (PubMed ID: 8454442)
1. Improved results in osteogenic sarcoma 1973-79 vs. 1980-86: analysis of results from a single center.
Cohen IJ; Kaplinsky C; Katz K; Mor C; Goshen Y; Yaniv Y; Avidor I; Yosipovitch Z; Zaizov R
Isr J Med Sci; 1993 Jan; 29(1):27-9. PubMed ID: 8454442
[TBL] [Abstract][Full Text] [Related]
2. [Limb salvage and amputation in osteosarcoma: report of 31 cases].
Zhang H; Luo X; Wang Z
Zhonghua Wai Ke Za Zhi; 1997 Sep; 35(9):556-7. PubMed ID: 10678034
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
[No Abstract] [Full Text] [Related]
4. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
[TBL] [Abstract][Full Text] [Related]
6. [Long-term follow-up results after heavy dose chemotherapy of primary malignant bone tumors of the limbs].
Cui TH
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):307-10. PubMed ID: 8174471
[TBL] [Abstract][Full Text] [Related]
7. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
8. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
[TBL] [Abstract][Full Text] [Related]
10. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
11. [Adjuvant chemotherapy of osteosarcoma].
Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemotherapy combined with caffeine for osteosarcoma.
Tsuchiya H; Yasutake H; Yokogawa A; Baba H; Ueda Y; Tomita K
J Cancer Res Clin Oncol; 1992; 118(8):567-9. PubMed ID: 1517277
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Saeter G; Wiebe T; Wiklund T; Monge O; Wahlqvist Y; Engström K; Forestier E; Holmström T; Stenwig AE; Willén H; Brosjö O; Follerås G; Alvegård TA; Strander H
Acta Orthop Scand Suppl; 1999 Jun; 285():74-82. PubMed ID: 10429627
[No Abstract] [Full Text] [Related]
14. Relationship between dose-intensity of treatment and outcome for patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Giacomini S; Lari S; Versari M
Oncol Rep; 2001; 8(4):883-8. PubMed ID: 11410803
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Kalifa C; Razafindrakoto H; Vassal G; Contesso G; Vanel D; Edeline V; Valteau D; Lemerle J
Cancer Treat Res; 1993; 62():347-9. PubMed ID: 7682093
[No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S
Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749
[No Abstract] [Full Text] [Related]
17. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.
Smeland S; Bruland OS; Hjorth L; Brosjö O; Bjerkehagen B; Osterlundh G; Jakobson A; Hall KS; Monge OR; Björk O; Alvegaard TA
Acta Orthop; 2011 Apr; 82(2):211-6. PubMed ID: 21434784
[TBL] [Abstract][Full Text] [Related]
18. Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan.
Ogihara Y; Sudo A; Fujinami S; Sato K; Miura T
Clin Orthop Relat Res; 1991 Sep; (270):72-8. PubMed ID: 1884562
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centres.
Jameson MB; Evans BD; Gray DH; Forgeson GV; Allan SG; Humm G; Thomson J; Thompson PI; Harvey VJ
Aust N Z J Med; 1995 Jun; 25(3):224-9. PubMed ID: 7487690
[TBL] [Abstract][Full Text] [Related]
20. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
